Header Logo

Connection

MURALI CHINTAGUMPALA to Retinal Neoplasms

Back to Details
This is a "connection" page, showing publications MURALI CHINTAGUMPALA has written about Retinal Neoplasms.
MURALI CHINTAGUMPALA
Connection Strength
4.647
Retinal Neoplasms
  1. A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1). Pediatr Blood Cancer. 2024 Jan; 71(1):e30718.
    View in: PubMed
    Score: 0.781
  2. Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321). J Clin Oncol. 2022 11 20; 40(33):3839-3847.
    View in: PubMed
    Score: 0.716
  3. Neonatal Retinoblastoma. Clin Perinatol. 2021 03; 48(1):53-70.
    View in: PubMed
    Score: 0.652
  4. A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231). Pediatr Blood Cancer. 2020 09; 67(9):e28502.
    View in: PubMed
    Score: 0.622
  5. Retinoblastoma: review of current management. Oncologist. 2007 Oct; 12(10):1237-46.
    View in: PubMed
    Score: 0.257
  6. Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir. J Clin Oncol. 2005 Nov 01; 23(31):7927-35.
    View in: PubMed
    Score: 0.225
  7. Children's Oncology Group's 2023 blueprint for research: Rare tumors. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30574.
    View in: PubMed
    Score: 0.192
  8. Response criteria for intraocular retinoblastoma: RB-RECIST. Pediatr Blood Cancer. 2021 05; 68(5):e28964.
    View in: PubMed
    Score: 0.163
  9. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study. J Clin Oncol. 2019 11 01; 37(31):2883-2891.
    View in: PubMed
    Score: 0.147
  10. Technical and anatomical factors affecting intra-arterial chemotherapy fluoroscopy time and radiation dose for intraocular retinoblastoma. J Neurointerv Surg. 2019 Dec; 11(12):1273-1276.
    View in: PubMed
    Score: 0.145
  11. Vitreous Seeds in Retinoblastoma: Clinicopathologic Classification and Correlation. Ophthalmology. 2017 10; 124(10):1540-1547.
    View in: PubMed
    Score: 0.125
  12. Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group. Pediatr Blood Cancer. 2017 Jul; 64(7).
    View in: PubMed
    Score: 0.122
  13. Correlation of Insurance, Race, and Ethnicity with Pathologic Risk in a Controlled Retinoblastoma Cohort: A Children's Oncology Group Study. Ophthalmology. 2016 08; 123(8):1817-1823.
    View in: PubMed
    Score: 0.117
  14. Residual intraretinal retinoblastoma after chemoreduction failure. Arch Ophthalmol. 2012 Feb; 130(2):246-8.
    View in: PubMed
    Score: 0.087
  15. Outcomes of integrating genetics in management of patients with retinoblastoma. Arch Ophthalmol. 2011 Nov; 129(11):1428-34.
    View in: PubMed
    Score: 0.085
  16. High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma. Pediatr Blood Cancer. 2010 Jul 15; 55(1):149-52.
    View in: PubMed
    Score: 0.078
  17. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 2009 Aug; 133(8):1199-202.
    View in: PubMed
    Score: 0.073
  18. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Arch Pathol Lab Med. 2006 Nov; 130(11):1669-72.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.